A Study of Insulin Glargine (LY2963016) in Healthy Chinese Participants

Inclusion Criteria

• Are native Chinese men or women. Native Chinese is defined as a participant who has both parents and all 4 grandparents of Chinese origin.
• For females of childbearing potential (defined as not surgically sterilised and between menarche and 1-year postmenopause) only:
• Negative serum pregnancy test at the time of screening.
• Are not lactating.
• Intend not to become pregnant during the study.
• Are sexually inactive or have practiced a reliable method of birth control for at least 6 weeks prior to screening.
• Agree to continue to use a reliable method of birth control (as determined by the investigator) during the study.
• For females not of childbearing potential, must be:
• Surgically sterile, defined as having had a hysterectomy or bilateral oophorectomy or tubal ligation, and/or
• Menopausal, defined as having had no menses for at least 1 year, or a plasma follicular stimulating hormone value of >40 milli-international units per milliliter (mIU/mL) and no menses for at least 6 months, unless the participant is taking hormone-replacement therapy.
• Having fasting plasma glucose 400 mL of blood in the last 6 months or donated >100 mL within the last 30 days.
• Have an average weekly alcohol intake that exceeds 21 units per week (males) and 14 units per week (females), or are unwilling to stop alcohol consumption while resident in the clinical research unit (CRU) (1 unit = 12 ounces or 360 mL of beer; 5 ounces or 150 mL of wine; 1.5 ounces or 45 mL of distilled spirits).
• Intend to use: prescription medication or over-the-counter medication or Chinese traditional medicine within 14 days before dosing (apart from vitamin/mineral supplements, occasional paracetamol, thyroid replacement, or birth control methods). If this situation arises, an otherwise suitable participant may be included at the discretion of the investigator.